Epigallocatechin

DB03823InvestigationalSmall molecule

Epigallocatechin: Overview.

Mechanism: Pharmacologically active on Angiotensin-converting enzyme, Acetylcholinesterase, and Pancreatic triacylglycerol lipase
Curator reviewed
Formula / weight: C₁₅H₁₄O₇ · 306.2675 g/mol (avg)
Also known as: Antiscurvy factor C2 · Epi-gallocatechin · Galloepicatechin · L-epigallocatechin
Code names: NSC-674039

Resolves to

Compound

Structure

InChIKeyXMOCLSLCDHWDHP-IUODEOHRSA-NSMILESO[C@@H]1CC2=C(O[C@@H]1C1=CC(O)=C(O)C(O)=C1)C=C(O)C=C2O

Targets

What you can answer from here — as of September 20, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Epigallocatechin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.